Feedback / Questions
Velsipity (etrasimod) - Pfizer
Velsipity: Expiry of patents in US/EU/Japan in 2029
(Pfizer)
-
Mar 4, 2024 -
Annual Report 2023: Term extension in US until 2034
Patent
•
Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis
https://d18rn0p25nwr6d.cloudfront.net/CIK-0000078003/1447e045-6320-4de3-a603-248c700cf342.pdf
Mar 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious